Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Medicine With Ketamine for Older Adults With Treatment-resistant Depression: Pilot Study

NCT04504175 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04504175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04504175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Medicine With Ketamine for Older Adults With Treatment-resistant Depression: Pilot Study
Lead sponsor
Washington University School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
October 22, 2020
Completion date
March 15, 2022
Enrollment
25 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

geriatric depression, late life depression, refractory depression, therapy-resistant depression, treatment resistant depression